Detailed data in the state’s opioid lawsuit illustrate how Purdue Pharma continued to push its most profitable drug OxyContin to high-volume providers in Tennessee despite evidence that those providers were Continue Reading
↧
Detailed data in the state’s opioid lawsuit illustrate how Purdue Pharma continued to push its most profitable drug OxyContin to high-volume providers in Tennessee despite evidence that those providers were Continue Reading